Published on 3 Jul 2022 on Simply Wall St. via Yahoo Finance

Investors one-year losses grow to 85% as the stock sheds US$29m this past week

It's not a secret that every investor will make bad investments, from time to time. But it's not unreasonable to try to avoid truly shocking capital losses. So spare a thought for the long term shareholders of DermTech, Inc. (NASDAQ:DMTK); the share price is down a whopping 85% in the last twelve months. That'd be enough to make even the strongest stomachs churn. DermTech hasn't been listed for long, so although we're wary of recent listings that perform poorly, it may still prove itself with time. Furthermore, it's down 65% in about a quarter. That's not much fun for holders. We really feel for shareholders in this scenario. It's a good reminder of the importance of diversification, and it's worth keeping in mind there's more to life than money, anyway.

After losing 15% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.

View our latest analysis for DermTech